F Paize, E Carrol, C Downey… - Pediatric Critical …, 2011 - journals.lww.com Wolters Kluwer Health may email you for journal alerts and information, but is committed to maintaining your privacy and will not share your personal information without your express consent. For more information, please refer to our Privacy Policy. ... Skip Navigation Links Home > ... Related articles - Check for Full Text - All 4 versions
Check for Full TextJ Brown, SL Aitken, M Mackey, S Sawkar… - Pharmacotherapy, 2011 - PPI Jack Brown, Pharm.D., MS, Samuel L. Aitken, Pharm.D., Melissa Mackey, Pharm.D., Sonia Sawkar, Pharm.D., and Elizabeth Dodds Ashley, Pharm.D., MHS ... Study Objective. To determine whether intravenous colistin therapy has an effect on the results of the ... Related articles - All 4 versions
DJ Guervil, AF Rosenberg… - The Annals of …, 2011 - Harvey Whitney Books The Annals of Pharmacotherapy ■ 2011 July/August, Volume 45 ■ ... Activated Partial Thromboplastin Time Versus Antifactor Xa ... Heparin Assay in Monitoring Unfractionated Heparin by ... David J Guervil, Amy F Rosenberg, Almut G Winterstein, Neil S Harris, Thomas E Johns, and ... Related articles - Check for Full Text - All 2 versions
Check for Full TextAE Miller, D Montague, JE Rodgers… - American Journal of …, 2011 - ASHP Summary Data were collected on patients receiving heparin therapy for selected indications (thrombotic disorders, cardiac conditions, and acute coronary syndromes) during four-month periods before (n = 59) and after (n = 60) implementation of the HCV-based nomograms. ... All 3 versions
K Yoshida… - US Patent 20,110,159,597, 2011 - freepatentsonline.com An activated partial thromboplastin time measuring reagent, comprising a heparin neutralizer is disclosed. An activated partial thromboplastin time measuring method, and a determination method for determining a presence or absence of a blood coagulation inhibitor are also ... Cached
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
